Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients

Clinical trial NCT01628393 · COMPLETED

Trial details

NCT number: NCT01628393
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2012-09-18
Primary completion: 2014-04-13
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.